Breaking News, Collaborations & Alliances

BioMed X Launches Research in Barbados for AI-Enabled Early Diabetic Kidney Disease Therapy

The research project is supported by the European Union’s PharmaNext Programme.

Author Image

By: Patrick Lavery

Content Marketing Editor

BioMed X, a pharmaceutical innovation hub, is partnering with the government of Barbados on research for AI-enabled therapy. Specifically, early diabetic kidney disease is this project’s focus. Within the Barbadian population, its biological heterogeneity is underexplored. A Need for AI Diabetes Therapy The molecular mechanisms driving disease in Barbadians with type 2 diabetes require understanding. What the project chiefly plans to construct is even more ambitious: a population-spe...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters